- Home
- SOND vs CLDI Comparison
SOND vs CLDI Comparison
Compare SOND & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- CLDI
- Stock Information
- Founded
- SOND 2014
- CLDI 2014
- Country
- SOND United States
- CLDI United States
- Employees
- SOND N/A
- CLDI N/A
- Industry
- SOND Hotels/Resorts
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOND Consumer Discretionary
- CLDI Health Care
- Exchange
- SOND Nasdaq
- CLDI Nasdaq
- Market Cap
- SOND 23.2M
- CLDI 20.2M
- IPO Year
- SOND N/A
- CLDI N/A
- Fundamental
- Price
- SOND $2.12
- CLDI $0.59
- Analyst Decision
- SOND
- CLDI
- Analyst Count
- SOND 0
- CLDI 0
- Target Price
- SOND N/A
- CLDI N/A
- AVG Volume (30 Days)
- SOND 56.2K
- CLDI 51.3M
- Earning Date
- SOND 07-23-2025
- CLDI 08-12-2025
- Dividend Yield
- SOND N/A
- CLDI N/A
- EPS Growth
- SOND N/A
- CLDI N/A
- EPS
- SOND N/A
- CLDI N/A
- Revenue
- SOND $621,272,000.00
- CLDI N/A
- Revenue This Year
- SOND $46.47
- CLDI N/A
- Revenue Next Year
- SOND N/A
- CLDI N/A
- P/E Ratio
- SOND N/A
- CLDI N/A
- Revenue Growth
- SOND 3.19
- CLDI N/A
- 52 Week Low
- SOND $0.88
- CLDI $0.20
- 52 Week High
- SOND $10.50
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- SOND 40.81
- CLDI 51.83
- Support Level
- SOND $2.11
- CLDI $0.56
- Resistance Level
- SOND $2.29
- CLDI $0.91
- Average True Range (ATR)
- SOND 0.17
- CLDI 0.10
- MACD
- SOND -0.10
- CLDI -0.02
- Stochastic Oscillator
- SOND 7.23
- CLDI 27.34
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.